Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)

SHA:603168 Revenue

Zhejiang Shapuaisi Pharmaceutical had revenue of 100.00M CNY in the quarter ending September 30, 2026, a decrease of -12.69%. This brings the company's total for the last twelve months to 408.66M, down -14.00% year-over-year. In the year 2025, Zhejiang Shapuaisi Pharmaceutical had annual revenue of 462.78M, down -4.38%. That makes Zhejiang Shapuaisi Pharmaceutical the 26,443rd largest company in the world by revenue and 4,630th in China.

• Revenue (ttm): 408.66M
• Revenue Growth: -14.00%
• P/S Ratio: 4.75
• Revenue / Employee: 357.85K
• Employees: 1,142
• Market Cap: 1.94B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Sale of Merchandise 312.77M 71.2%
• Medical Service 126.60M 28.8%

Fiscal year ended Dec 31, 2025 See the full SHA:603168 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	462.78M	-21.18M	-4.38%
Dec 31, 2024	483.96M	-161.01M	-24.96%
Dec 31, 2023	644.97M	95.43M	17.37%
Dec 31, 2022	549.54M	-80.23M	-12.74%
Dec 31, 2021	629.76M	282.96M	81.59%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error